FDA to allow greater flexibility for clinical investigators about informed consent
The FDA is proposing to amend its regulations to implement a provision of the 21st Century Cures Act and add an exception to informed consent requirements for certain FDA-regulated clinical investigations that present no more than minimal risk to human research participants. November 13, 2018